Lipopolysaccharide from E. coli (O55:B5)

Lipopolysaccharide extracted from E. coli (wild-type S-form, serotype O55:B5)

Lipopolysaccharide from E. coli (O55:B5)

Lipopolysaccharide extracted from E. coli (wild-type S-form, serotype O55:B5)

From: 289 USD
Catalog #
(Select a product)
Lipopolysaccharide extracted from E. coli (wild-type S-form, serotype O55:B5)
Add to Wish List

Overview

Trigger a variety of immunological responses with E. coli Lipopolysaccharide O55:B5 (S-form), a lipopolysaccharide (LPS) derived from the O55:B5 serotype of the Gram-negative bacteria Escherichia coli. Composed of a lipid A, a core oligosaccharide, and an O antigen, LPS are glycolipid constituents that reside on the outer membranes of Gram-negative bacteria (Kitchens RL et al.). LPS protects bacteria against bile salts and lipophilic antibiotics by maintaining the outer integrity of the cell membrane (Bäckhed F et al.). E. coli Lipopolysaccharide O55:B5 (S-form), in particular, is predominantly recognized by toll-like receptor 4 (TLR4), which leads to the activation of NF-κβ, a protein complex which plays a key role in regulating immune response (Kuzmich N et al.). Activation of NF-κβ can trigger increased production of pro-inflammatory cytokines IL-1 and TNF-α by macrophages (Matuschak GM et al.). This LPS can also interact with CD14 to activate phospholipase Cγ2 and kinases of the Src family, trigger influxes of extracellular Ca2+, as well as calcineurin-dependent translocation of the nuclear factor of activated T cells (NFAT) family of transcription factors (Li CC et al.).
When added to ImmunoCult™-SF Macrophage Medium (Catalog #10961), stimulation with Lipopolysaccharide from E. coli (O55:B5) and IFN-γ supports the polarization to M1 (classically activated) macrophages.


Warning: This product is highly pyrogenic. Avoid all means by which the product may enter the bloodstream.

Application
Activation, Cell Culture
Area of Interest
Immunology, Infectious Diseases, Neuroscience
Purity
Ultrapure (≥ 99.9%). No detectable DNA, RNA, or protein traces.

Data Figures

Figure 1. Stimulation with Lipopolysaccharide from E. coli (O55:B5) Resulted in High Production of IL-6 through TLR4-specific Activation

The biological activity of Lipopolysaccharide (LPS) from E. coli (O55:B5) was assessed by its ability to activate TLR4 in both wild-type and TLR4 knockout (KO) mouse macrophages, with a medium-only negative control. When stimulated with 1 μg/mL of LPS from E. coli (O55:B5), wild-type mouse macrophages produced ≥ 9200 pg/mL of IL-6, as measured by ELISA in cell culture supernatants after 24 hours. IL-6 production in TLR4 KO macrophages was comparable to the medium-only negative control, indicating that activation by LPS from E. coli (O55:B5) did not activate any TLR other than TLR4. The optimal concentration required for activation is 0.01 - 1 μg/mL.

Protocols and Documentation

Find supporting information and directions for use in the Product Information Sheet or explore additional protocols below.

Document Type
Product Name
Catalog #
Lot #
Language
Catalog #
100-1270
Lot #
All
Language
English
Document Type
Safety Data Sheet
Catalog #
100-1270
Lot #
All
Language
English

Applications

This product is designed for use in the following research area(s) as part of the highlighted workflow stage(s). Explore these workflows to learn more about the other products we offer to support each research area.